Westheim A - Search Results

1

Lower plasma noradrenaline and blood viscosity on carvedilol vs atenolol in men with recent myocardial infarction.

Jonsson G, Fossum E, Kjeldsen SE, Høieggen A, Os I, Eide I, Westheim A. Jonsson G, et al. Among authors: westheim a. Blood Press. 2002;11(6):377-84. doi: 10.1080/080370502321095357. Blood Press. 2002. PMID: 12523682 Free article. Clinical Trial.

2

The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients.

Jonsson G, Abdelnoor M, Seljeflot I, Arnesen H, Hostmark AT, Kjeldsen SE, Os I, Westheim AS. Jonsson G, et al. J Cardiovasc Pharmacol. 2007 Jan;49(1):27-32. doi: 10.1097/FJC.0b013e31802bdd8c. J Cardiovasc Pharmacol. 2007. PMID: 17261960 Clinical Trial.

3

Do screening blood pressure and plasma catecholamines predict development of hypertension? Twenty-year follow-up of middle-aged men.

Gudmundsdottir H, Strand AH, Høieggen A, Reims HM, Westheim AS, Eide IK, Kjeldsen SE, Os I. Gudmundsdottir H, et al. Among authors: westheim as. Blood Press. 2008;17(2):94-103. doi: 10.1080/08037050801972923. Blood Press. 2008. PMID: 18568698 Free article.

4

A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients.

Jonsson G, Abdelnoor M, Müller C, Kjeldsen SE, Os I, Westheim A. Jonsson G, et al. Among authors: westheim a. Cardiology. 2005;103(3):148-55. doi: 10.1159/000084584. Epub 2005 Mar 21. Cardiology. 2005. PMID: 15785019 Clinical Trial.

5

Prevention of cardiovascular events and diabetes with angiotensin-receptor blockers in hypertension: LIFE, SCOPE, and VALUE.

Kjeldsen SE, Westheim AS, Os I. Kjeldsen SE, et al. Curr Hypertens Rep. 2005 Jun;7(3):155-7. doi: 10.1007/s11906-005-0001-8. Curr Hypertens Rep. 2005. PMID: 15913486 Review. No abstract available.

6

The angiotensin receptor antagonist valsartan: a review of the literature with a focus on clinical trials.

Mistry NB, Westheim AS, Kjeldsen SE. Mistry NB, et al. Expert Opin Pharmacother. 2006 Apr;7(5):575-81. doi: 10.1517/14656566.7.5.575. Expert Opin Pharmacother. 2006. PMID: 16553573 Review.

7

Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years.

Strand AH, Gudmundsdottir H, Os I, Smith G, Westheim AS, Bjørnerheim R, Kjeldsen SE. Strand AH, et al. J Hypertens. 2006 May;24(5):905-13. doi: 10.1097/01.hjh.0000222761.07477.7b. J Hypertens. 2006. PMID: 16612253

8

Treatment of hypertension in patients with congestive cardiac failure.

Mistry NB, Westheim AS, Kjeldsen SE. Mistry NB, et al. Heart Fail Monit. 2006;5(2):38-43. Heart Fail Monit. 2006. PMID: 16816875 Review.

9

N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.

Jonsson G, Abdelnoor M, Landaas S, Muller C, Kjeldsen SE, Os I, Westheim A. Jonsson G, et al. Among authors: westheim a. Cardiology. 2006;106(2):102-8. doi: 10.1159/000092743. Epub 2006 Apr 21. Cardiology. 2006. PMID: 16636540

10

Could adverse events offset the benefit of intensive blood pressure lowering treatment in the Systolic Blood Pressure Intervention Trial?

Kjeldsen SE, Os I, Westheim A. Kjeldsen SE, et al. Among authors: westheim a. J Hypertens. 2019 May;37(5):902-904. doi: 10.1097/HJH.0000000000002018. J Hypertens. 2019. PMID: 30920495 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters